Legal & General Group
SANA icon

Legal & General Group’s Sana Biotechnology SANA Stock Holding History

Legal & General Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
136,181
+9,764
+8% +$31.5K ﹤0.01% 2415
2026
Q1 		$364K Sell
126,417
-24,601
-16% -$96.9K ﹤0.01% 2442
2025
Q4 		$615K Buy
151,018
+21,761
+17% +$97.4K ﹤0.01% 2354
2025
Q3 		$459K Buy
129,257
+82,459
+176% +$298K ﹤0.01% 2474
2025
Q2 		$128K Sell
46,798
-114,071
-71% -$235K ﹤0.01% 2626
2025
Q1 		$270K Sell
160,869
-308
-0.2% -$861 ﹤0.01% 2566
2024
Q4 		$263K Buy
161,177
+6,797
+4% +$20.3K ﹤0.01% 2631
2024
Q3 		$642K Buy
154,380
+2,876
+2% +$15.1K ﹤0.01% 2376
2024
Q2 		$827K Buy
151,504
+43,857
+41% +$349K ﹤0.01% 2257
2024
Q1 		$1.08M Buy
107,647
+17,700
+20% +$133K ﹤0.01% 2167
2023
Q4 		$367K Hold
89,947
– – ﹤0.01% 2568
2023
Q3 		$348K Sell
89,947
-874
-1% -$4.7K ﹤0.01% 2571
2023
Q2 		$541K Buy
90,821
+20,812
+30% +$120K ﹤0.01% 2437
2023
Q1 		$229K Buy
70,009
+2,443
+4% +$9.76K ﹤0.01% 2543
2022
Q4 		$267K Hold
67,566
– – ﹤0.01% 2505
2022
Q3 		$406K Buy
67,566
+1,864
+3% +$13.5K ﹤0.01% 2401
2022
Q2 		$422K Buy
65,702
+9,984
+18% +$63.6K ﹤0.01% 2386
2022
Q1 		$461K Buy
55,718
+37,020
+198% +$299K ﹤0.01% 2415
2021
Q4 		$290K Buy
18,698
+9,140
+96% +$176K ﹤0.01% 2581
2021
Q3 		$215K Buy
9,558
+6,096
+176% +$128K ﹤0.01% 2669
2021
Q2 		$68K Buy
3,462
+150
+5% +$3.4K ﹤0.01% 2863
2021
Q1 		$111K Buy
+3,312
New +$108K ﹤0.01% 2590

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Legal & General Group's SANA Position: Q2 2026 in Review

Legal & General Group increased its Sana Biotechnology (SANA) stake by 7.7% in Q2 2026, buying an estimated $31.5K and bringing the position to 136,181 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #2415.

Legal & General Group first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.08M in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Legal & General Group held 136,181 shares of Sana Biotechnology worth $475K as of Q2 2026.
  • Legal & General Group bought 9,764 Sana Biotechnology shares in Q2 2026, an estimated $31.5K.
  • Sana Biotechnology made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2415 holding.
  • Legal & General Group first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Legal & General Group's Sana Biotechnology position peaked at $1.08M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.